Patterns of lymph node metastasis in locally advanced cervical cancer.
The aim of this study was to investigate patterns and locations of lymph node metastasis in locally advanced cervical cancers.A total of 244 consecutive patients with stage IIb cervical cancer were retrospectively evaluated. Contrast-enhanced CT scans were used for lymph node grading. Lymph nodes with the shortest axis (>1 cm) were categorized as positive and those between 0.5 and 1 cm were categorized as suspicious. All lymph nodes (LNs) were also classified by their anatomic locations.Nine hundred thirty-one LNs (136 positive and 795 suspicious) were identified. Sixty-three (25.8%) patients had positive LNs, and 153 (62.7%) patients had only suspicious LNs. The metastatic pattern was predictable traveling from level 1 (external iliac, internal iliac, obturator, and mesorectum groups) through level 2 (common iliac and presacral groups) to level 3 (para-aortic groups). In most groups, LNs were located within 1.0 cm of main blood vessels. Our novel findings were: presacral LNs metastases were rare (2/244, 0.82%); the left common iliac group (LCI) had significantly more enlarged nodes than the right common iliac group (P = 0.00); the LCI and left down-para-aortic group were further away from blood vessels than expected (1.2 cm and 1.4 cm, respectively); no additional margin was needed in anterolateral direction for external iliac groups.The lymph node metastatic patterns are relatively predicable. Different expansions from vessels should be used to include LNs for different groups. Presacral nodes metastases are rare, and further study is warranted to see whether this region can be excluded from nodal CTV.
aRadiation Oncology, Peking Union Medical College Hospital bRadiation Oncology, City of Hope Medical Center.
Zhikai
Z
Liu
Ke
K
Hu
An
A
Liu
Jie
J
Shen
Xiaorong
X
Hou
Xin
X
Lian
Shuai
S
Sun
Junfang
J
Yan
Fuquan
F
Zhang
D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000473:pathology*
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):428-34
18037584
Gynecol Oncol. 2012 Apr;125(1):168-74
22155677
Gynecol Oncol. 1990 Sep;38(3):421-4
2227555
Gynecol Oncol. 2005 Apr;97(1):183-91
15790456
Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1147-52
12419442
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1613-21
11121668
AJR Am J Roentgenol. 2000 Sep;175(3):759-66
10954463
Ann Surg Oncol. 2013 Feb;20(2):413-22
22911367
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):348-55
20472347
Gynecol Oncol. 1996 Jul;62(1):19-24
8690286
Radiat Oncol. 2013 Jun 08;8:139
23758698
Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):167-72
12118547
Future Oncol. 2015;11(2):309-22
25591841
Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):261-6
11516876
Radiology. 1994 Feb;190(2):315-22
8284375
Gynecol Oncol. 2006 Oct;103(1):35-44
16600355
Int J Gynecol Cancer. 2014 Jun;24(5):916-22
24442006
Clin Radiol. 1999 Apr;54(4):237-42
10210343
AJR Am J Roentgenol. 1997 Aug;169(2):521-5
9242768
Strahlenther Onkol. 2012 Jul;188(7):568-75
22618361
Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):959-62
8244829
Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):649-56
11020560
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1604-12
16198509